Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by AKAMPION
< Previous
1
2
Next >
Cellbox Solutions Submits Device Master File (DMF) to the U.S. FDA
September 25, 2023
From
AKAMPION
Via
GlobeNewswire
1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab)
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Establishes High-Profile Clinical Advisory Board
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Appoints Dr. Constanze Guenther as Senior Vice President, CMC and Technical Development
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Reports Positive One-Year Patient Follow-Up Data for Resorbable Breast and Pectus Excavatum Scaffolds
September 05, 2023
From
AKAMPION
Via
GlobeNewswire
TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing
July 06, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Granted Market Access in Europe for Custom-Made Bone and Pectus Excavatum Scaffolds
July 06, 2023
From
AKAMPION
Via
GlobeNewswire
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
July 05, 2023
From
AKAMPION
Via
GlobeNewswire
Oliver Healthcare Packaging Strengthens Supply Chain, Adds In-Region Film & Foil Production
June 29, 2023
From
AKAMPION
Via
GlobeNewswire
Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active
June 28, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Demonstrates Superior Biomechanical Properties of its 3-D Printed, Resorbable Scaffolds for Bone Reconstruction
June 20, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment
June 20, 2023
From
AKAMPION
Via
GlobeNewswire
MetrioPharm Receives Orphan Drug Designation for the Treatment of Duchenne Muscular Dystrophy
May 30, 2023
From
AKAMPION
Via
GlobeNewswire
selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis
May 30, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001
May 24, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002
May 24, 2023
From
AKAMPION
Via
GlobeNewswire
Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer
May 12, 2023
From
AKAMPION
Via
GlobeNewswire
Positive Interim Data of BellaSeno's Clinical Trial with Resorbable Breast and Chest Implants Reported at RACS 2023
May 09, 2023
From
AKAMPION
Via
GlobeNewswire
Omnix Medical Announces Excellent Topline Data from the Phase I Clinical Trial of its Novel Anti-Infective OMN6
May 08, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Appoints Michael A. Curran, PhD, as Chairman of its Scientific Advisory Board
April 25, 2023
From
AKAMPION
Via
GlobeNewswire
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
April 12, 2023
From
AKAMPION
Via
GlobeNewswire
EBViously Announces First Details of Its EBV-001 Vaccine Candidate for the Prevention of Epstein-Barr Virus (EBV)-Induced Diseases
April 03, 2023
From
AKAMPION
Via
GlobeNewswire
InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Health
March 28, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001
March 28, 2023
From
AKAMPION
Via
GlobeNewswire
HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration
March 27, 2023
From
AKAMPION
Via
GlobeNewswire
Dopavision Appoints Prof. Dr. Jens Ellrich as Chief Scientific Officer
March 21, 2023
From
AKAMPION
Via
GlobeNewswire
Cellbox Solutions Raises EUR 6.5 Million in Series A1 Financing Round
March 07, 2023
From
AKAMPION
Via
GlobeNewswire
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
March 06, 2023
From
AKAMPION
Via
GlobeNewswire
Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board
February 23, 2023
From
AKAMPION
Via
GlobeNewswire
Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor
January 25, 2023
From
AKAMPION
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.